| Faculty Name | Area of Expertise | |
|---|---|---|
| Ruben Abagyan, Ph.D. | Computational Drug Design | |
| Adah Almutairi, Ph.D. | Nanotechnology Technological in Drug Delivery & Diagnostics | |
| David Bailey, Ph.D. | Analytical Toxicology | |
| Nuno Bandeira, Ph.D. | Computational Proteomics and Mass Spectrometry | |
| Philip Bourne, Ph.D. | Computational Drug Discovery, Polypharmacology | |
| Geoffrey Chang, Ph.D. | Structural Biology | |
| Pieter Dorrestein, Ph.D. | Analytical Mass Spectrometry | |
| Sylvia Evans, Ph.D. | Cardiology, Cardiac Stem Cells | |
| William Gerwick, Ph.D. | Natural Products, Cyanobacteria, Oncology & Infectious Disease | |
| Michael Gilson, M.D., Ph.D. | Computer-Aided Drug Design, Biophysical Theory and Modeling | |
| Åsa Gustafsson, Ph.D. | Cardiovascular Research | |
| James Halpert, Ph.D. | Drug Metabolism | |
| Tracy Handel, Ph.D. | Structural Studies of chemokines and their G Protein-Coupled Receptors | |
| Vivian Hook, Ph.D. | Peptide and Protease Pharmacology, Neurological & Degenerative Disease | |
| Marianne Manchester, Ph.D. | Drug Discovery | |
| Tadeusz Molinski, Ph.D. | Natural Products Drug Design | |
| Bradley Moore, Ph.D. | Marine Genomics & Drug Development | |
| Victor Nizet, M.D. | Infectious Disease & Immunology, Antimicrobial Drug Discovery | |
| Ana Pajor, Ph.D. | SLC Transporters | |
| Marion Sewer, Ph.D. | Molecular Endocrinology | |
| Deborah Spector, Ph.D. | Virus & Vaccines | |
| Palmer Taylor, Ph.D. | Neuropharmacology, Molecular Recognition | |
| Dong Wang, Ph.D. | Transcription, DNA damage & Repair Anticancer Drugs |
| Faculty Name | Area of Expertise | |
|---|---|---|
| David Adler, Pharm.D. | Anticoagulant Therapy | |
| Rabia Atayee, Pharm.D., BCPS | Palliative Care | |
| Linda Awdishu, Pharm.D., MAS | Chronic Kidney Disease Therapy and Kidney Transplantation | |
| Brookie Best, Pharm,D., M.A.S. | Clinical Pharmacology Research | |
| James Colbert, Pharm.D. | Experiential Education, Pediatrics and Pharmacy Leadership | |
| Charles Daniels, R.Ph., Ph.D. FASHP | Pharmacoeconomics & Medication Use systems | |
| Eduardo Fricovsky, Pharm.D. | Underserved Populations Access to Pharmacotherapy | |
| Jan Hirsch, R.Ph., Ph.D. | Pharmacoeconomics | |
| Doug Humber, Pharm.D. | Cardiology | |
| Farivar Jahansouz, Pharm.D. | Crticial Care; Cardiovascular surgery; Pulmonary hypertension | |
| Grace Kuo, Pharm.D., M.P.H, Ph.D. | Medication Safety, Medication Therapy Management, Pharmacogenomics | |
| Jennifer Le, Pharm.D., BCPS-ID | Infectious Diseases | |
| Kelly C. Lee, Pharm.D., BCPP | Neuropsychiatry, Medication Therapy Management, Pharmacogenomics | |
| Joe Ma, Parm.D. | Clinical Pharmacology | |
| Anthony S. Manoguerra, Pharm.D. | Poison Control | |
| Sarah McBane, Pharm.D., CDE, BCPS | Family Medicine | |
| Candis Morello, Pharm.D., CDE | Diabetes Prevention & Therapy | |
| Jennifer Namba, Pharm.D., BCPS | Acute Care/Intensive Care | |
| Nathan Painter, Pharm.D., CDE | Family Medicine | |
| Kenneth Schell, Pharm.D. | Pediatric Pharmacy | |
| Renu F. Singh, Pharm.D., BCACP, CDE | Family Medicine | |
| Shirley M. Tsunoda, Pharm.D. | Transplantation and Liver Disease | |
| Felix Yam, Pharm.D., BCPS | Acute Care/Critical Care |
